Notice NOT-OD-21-165 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-286 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research. This FOA is specifically for core/shared resource/central scientific support scientists. The Research Specialist Award is designed to encourage the development of stable research career opportunities for exceptional scientists who want to continue to pursue research within the context of an existing NCI-funded basic, translational, clinical, or population science cancer research program, but not serve as independent investigators. These scientists, such as researchers within a core/shared resource/central scientific support, are vital to sustaining the biomedical research enterprise. The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.

Notice NOT-TW-21-007 from the NIH Guide for Grants and Contracts

Notice NOT-AR-21-026 from the NIH Guide for Grants and Contracts

Notice NOT-NS-22-004 from the NIH Guide for Grants and Contracts

Notice NOT-AA-21-036 from the NIH Guide for Grants and Contracts

Notice NOT-OD-21-134 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-290 from the NIH Guide for Grants and Contracts. Through this funding opportunity announcement (FOA), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.

Competitive Salary: EMBL: The Ensembl Project, based at the European Bioinformatics Institute (EMBL-EBI), is one of the leading providers of genome annotation globally. We seek Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: Training is a core activity across EMBL-EBI, involving almost every part of the organisation and coordinated by a team of around 30 people. The Traini Hinxton, Cambridgeshire, England

Competitive Salary: EMBL: ELIXIR is seeking an experienced data scientist to coordinate and organise technical architecture and complex projects within the dynamic and internat Hinxton, Cambridgeshire, England

Notice NOT-AA-21-035 from the NIH Guide for Grants and Contracts

Competitive Salary + Excellent Benefits : CY Partners: Bioinformatics research into biomarkers, genetic analysis & other data pertaining to Traditional Chinese Herbal Remedies, Medicines and Supplements. London (Greater) (GB)

Funding Opportunity RFA-AG-22-023 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit a cooperative agreement (U24) application for a Data Management and Coordinating Center (DMCC) which will support the integration of research activities across a group of ongoing human longevity translational projects and assume responsibilities for the management and expansion of the existing NIA Exceptional Longevity Portal (EL Portal). Specifically, the DMCC will facilitate and support collaborative research activities across the human longevity translational projects, manage the deposition and distribution of data and resources generated by these projects, as well as oversee outreach to and engagement of the broader scientific community to analyze the resources hosted by the EL Portal. The DMCC will also create a collaborative research workspace by leveraging the existing infrastructure of the NIA EL portalan interoperable resource, a scalable data commons which will combine multidimensional data, cloud computing, and software tools in a secure environment to allow investigators to access, deposit, and analyze different data types from multiple sources to accelerate the translation of molecular factors contributing to exceptional health and life span.

Funding Opportunity RFA-DA-22-033 from the NIH Guide for Grants and Contracts. The National Institute on Drug Abuse (NIDA) supports a program of longitudinal cohorts to address emerging and high priority research on HIV/AIDS in the context of injection and non-injection substance abuse. These cohorts provide a strong resource platform for current and future collaborative efforts with other investigators to address emerging questions related to HIV pathogenesis, prevention, and treatment in the context of substance abuse, as well as to foster the creativity and efficiency of investigatorinitiated research projects. The diverse research activities among these cohorts include basic immunologic, and virologic studies, as well as studies on HIV prevention and treatment, and the co-morbidities and co-infections associated with HIV and substance abuse. NIDA has determined that a coordinating center (CC) is needed in order to take advantage of these rich sources of data and bio-specimens and optimize collaborations among both the cohort investigators and other researchers not funded under the cohort program. In addition, the CC is expected to establish a virtual repository, and facilitate the leadership of the cohorts steering committee (SC), consisting of representatives from the NIDA-funded cohorts and NIDA staff.

Funding Opportunity PAR-21-294 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain fundamental insights into cancer inflammation in vivo. The motivation for this initiative is that much of current imaging research into the role of inflammation in cancer is largely based on in vitro and ex vivo methods with limited utilization of imaging approaches that could lead to significant new insights relevant to dynamic cancer and inflammation interactions. Utilization of molecular imaging probes in pre-clinical and clinical investigations for precise temporal resolution at the molecular and cellular level are valuable approaches for identification and characterization of in vivo inflammatory cellular physiology in cancers and of molecular changes in response to treatment. This FOA encourages applications that focus on developing integrated imaging approaches to interrogate the role of inflammation in cancer through strong cross-field collaboration between cancer basic science researchers and imaging scientists. These collaborations are expected to advance science and understanding of cancer inflammation interactions.

Notice NOT-AI-21-066 from the NIH Guide for Grants and Contracts

Notice NOT-HL-21-018 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-099 from the NIH Guide for Grants and Contracts

Notice NOT-CA-21-098 from the NIH Guide for Grants and Contracts